Previously submitted to: Interactive Journal of Medical Research (no longer under consideration since Oct 21, 2024)
Date Submitted: May 11, 2023
Open Peer Review Period: May 11, 2023 - Jul 6, 2023
(closed for review but you can still tweet)
NOTE: This is an unreviewed Preprint
Warning: This is a unreviewed preprint (What is a preprint?). Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn (a note "no longer under consideration" will appear above).
Peer review me: Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period (in this case, a "Peer Review Me" button to sign up as reviewer is displayed above). All preprints currently open for review are listed here. Outside of the formal open peer-review period we encourage you to tweet about the preprint.
Citation: Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author).
Final version: If our system detects a final peer-reviewed "version of record" (VoR) published in any journal, a link to that VoR will appear below. Readers are then encourage to cite the VoR instead of this preprint.
Settings: If you are the author, you can login and change the preprint display settings, but the preprint URL/DOI is supposed to be stable and citable, so it should not be removed once posted.
Submit: To post your own preprint, simply submit to any JMIR journal, and choose the appropriate settings to expose your submitted version as preprint.
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Evaluation of an Acne Scar Gel's Effectiveness, Quality of Life, and Patient Satisfaction in Facial Acne Treatment: A Multicenter Observational Study
ABSTRACT
Background:
Acne is the most common skin disorder which is known as a chronic inflammatory disease with psychological burden and reduce quality of life.
Objective:
The objective of this study is to determine, in a real-life setting, effectiveness of Clinical Experience which includes Reduction in Depth, Erythema, Diameter and Pigmentation with Acne Scar Gel, and to evaluate the effect of the product on Quality of life.
Methods:
Overall 435 patients were assessed for 90 days. The acne scars were counted and classified as mild, moderate or severe and the type of acne scar was registered. The study participants have gone through both oral and topical and for a time range of 1 week to over a month depending on the severity of the scars. They have also gone through medical procedures as per the requirement. The results were assessed at the intervals of 30 days to 90 days and were graded between 1-5
Results:
Overall facial appearance of atrophic acne scars improved after treatment with acne scar gel. Clinical experience with acne scar gel (in terms of reduction depth, erythema, diameter and pigmentation) and subject satisfaction with the happiness score and with the sensation and perception of the skin improved in most subjects. Subjects' self-esteem and self-confidence also improved.
Conclusions:
Acne scar gel was effective and safe for treatment of moderate-to-severe acne scars. The acne scar gel can be used as topical treatment for acne scars, thereby minimizing the need of procedural treatment for acne scars.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.